A Prospective, Multicenter Study to Investigate the Pharmacokinetics, Safety, and Efficacy of Cadazolid Versus Vancomycin in Pediatric Subjects With Clostridium Difficile-associated Diarrhea

Trial Profile

A Prospective, Multicenter Study to Investigate the Pharmacokinetics, Safety, and Efficacy of Cadazolid Versus Vancomycin in Pediatric Subjects With Clostridium Difficile-associated Diarrhea

Discontinued
Phase of Trial: Phase II/III

Latest Information Update: 07 Aug 2018

At a glance

  • Drugs Cadazolid (Primary) ; Vancomycin
  • Indications Clostridium-difficile-infections; Diarrhoea
  • Focus Pharmacokinetics; Therapeutic Use
  • Sponsors Actelion Pharmaceuticals
  • Most Recent Events

    • 30 May 2018 This trial has been completed in Hungary (end date: 2018-04-17).
    • 23 May 2018 Status changed from suspended to discontinued.
    • 22 Nov 2017 Status changed from recruiting to suspended.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top